Opus Genetics, Inc. (IRD) — Cash Flow Quality Index
Latest as of September 2023:
-0.54x
Opus Genetics, Inc. (IRD) has a Cash Flow Quality Index of -0.54x as of September 2023. Operating cash flow of $-3.00 Million is below net income of $5.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore IRD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.54x
Operating CF / Net Income
Operating Cash Flow
$-3.00 Million
USD
Net Income
$5.56 Million
USD
Data as of
Sep 2023
Most recent filing
Opus Genetics, Inc. Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Opus Genetics, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see IRD cash generation efficiency.
Annual Cash Flow Quality Index for Opus Genetics, Inc. (2022–2022)
Year-by-year earnings quality comparison for Opus Genetics, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.80x | $14.31 Million | $17.89 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.